PTEN loss and ERG expression have been described less frequently in ductal carcinoma compared to acinar carcinoma [102]; however, both markers may be observed in ductal carcinoma; hence, they cannot be used as a reliable factor for differential diagnosis between the two entities. This evidence concerns the gene PTEN and breast ductal adenocarcinoma.